Effect of Direct Thrombin Inhibitors, Bivalirudin, Lepirudin, and Argatroban, on Prothrombin Time and INR Values

American Journal of Clinical Pathology

Volumn 121, Issue 4, 2004, Pages 593-599

  Gosselin, Robert C ^a   Dager, William E ^a   King, Jeffrey H ^a   Janatpour, Kim ^a   Mahackian, Kathleen ^a   Larkin, Edward C ^a   Owings, John T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Argatroban; Bivalirudin; Direct thrombin inhibitors; INR; International normalized ratio; Lepirudin; Prothrombin time

Indexed keywords

ARGATROBAN; FIBRINOGEN; HIRULOG; LEPIRUDIN; PROTHROMBIN; REAGENT; THROMBIN INHIBITOR;

ANALYSIS OF VARIANCE; ANTICOAGULATION; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; HUMAN; INTERNATIONAL COOPERATION; INTERNATIONAL STANDARD UNIT; LONG TERM CARE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOSIS PREVENTION;

EID: 1642317572     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/D79K4YG78NTNYY38     Document Type: Article

References (8)

1. Dager WE, White RH. Pharmacotherapy of heparin-induced thrombocytopenia. Expert Opin Pharmacother. 2003;4:919-940.
2. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121:535-555.
3. Sheth SB, DiCicco RA, Hursting MJ, et al. Interpreting the international normalized ratio (INR) in individuals receiving argatroban and warfarin [published correction appears in Thromb Haemost. 2001;86:727]. Thromb Haemost. 2001;85:435-440.
4. Sheth SB, DiCicco RA, Hursting MJ, et al. Interpreting the international normalized ratio (INR) in individuals receiving argatroban and warfarin [published correction appears in Thromb Haemost. 2001;86:727]. Thromb Haemost. 2001;85:435-440.
5. Hursting MJ, Zehnder JL, Joffrion JL, et al. The international normalized ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used. Clin Chem. 1999;45:409-412.
6. Fenyvesi T, Jorg I, Harenberg J. Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PiCT method. Pathophysiol Haemost Thromb. 2002;32:174-179.
7. Fox I, Dawson A, Loynds P, et al. Anticoagulant activity of hirulog, a direct thrombin inhibitor, in humans. Thromb Haemost. 1993;69:157-163.
8. Walenga JM, Fasanella AR, Iqbal O, et al. Coagulation laboratory testing in patients treated with argatroban. Semin Thromb Hemost. 1999;25(suppl 1):61-66.